{"DataElement":{"publicId":"4975799","version":"2","preferredName":"Disease or Disorder Children's Oncology Group Stage Tumor Stage","preferredDefinition":"The disease stage based on Children's Oncology Group standards.","longName":"COGDszIdnTmStg","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"4975700","version":"1","preferredName":"Disease or Disorder Children's Oncology Group Stage","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers._The extent of a cancer in the body.","longName":"4975697v1.0:4982139v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7781211","version":"1","preferredName":"Children's Oncology Group Stage","preferredDefinition":"An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C39353:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Children's Oncology Group","conceptCode":"C39353","definition":"An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB6DAAE3-094F-3BA3-E053-4EBD850A1260","latestVersionIndicator":"Yes","beginDate":"2021-09-07","endDate":null,"createdBy":"MENARDP","dateCreated":"2021-09-07","modifiedBy":"ONEDATA","dateModified":"2021-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1DB2743D-D36A-8DB9-E050-BB89AD43759D","latestVersionIndicator":"No","beginDate":"2015-08-19","endDate":"2021-09-08","createdBy":"DAVISJ","dateCreated":"2015-08-19","modifiedBy":"MENARDP","dateModified":"2021-09-10","changeDescription":"Workflow and Registration Status Changed per Brenda Duggan; 05.16.18 DDEC modified for AGCT1531. Object class primary concept, property qualifier concept, and property primary concept changed. PM9/7/21","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018913","version":"1","preferredName":"Tumor Stage","preferredDefinition":"the extent of tumor disease following standard criteria specified in a protocol.","longName":"TUMOR_ST","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"0","valueDescription":"No Evidence of Disease","ValueMeaning":{"publicId":"2559523","version":"1","preferredName":"No Evidence of Disease","longName":"2559523","preferredDefinition":"Diagnostic tests fail to detect presence of disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No Evidence of Disease","conceptCode":"C40413","definition":"Diagnostic tests fail to detect presence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B590-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD415FAB-5830-0AA0-E034-0003BA12F5E7","beginDate":"2003-05-09","endDate":null,"createdBy":"PWEST","dateCreated":"2003-05-09","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"1","valueDescription":"I","ValueMeaning":{"publicId":"2558891","version":"1","preferredName":"I","longName":"2558891","preferredDefinition":"Stage I","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B318-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD415FAB-5832-0AA0-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-05-09","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"2","valueDescription":"II","ValueMeaning":{"publicId":"2565932","version":"1","preferredName":"II","longName":"2565932","preferredDefinition":"Stage II","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CE99-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-09","endDate":null,"createdBy":"PWEST","dateCreated":"2003-05-09","modifiedBy":"CURTIST","dateModified":"2007-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD415FAB-5835-0AA0-E034-0003BA12F5E7","beginDate":"2003-05-09","endDate":null,"createdBy":"PWEST","dateCreated":"2003-05-09","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"3","valueDescription":"III","ValueMeaning":{"publicId":"2558915","version":"1","preferredName":"III","longName":"2558915","preferredDefinition":"Stage III","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B330-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CURTIST","dateModified":"2009-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD415FAB-5838-0AA0-E034-0003BA12F5E7","beginDate":"2003-05-09","endDate":null,"createdBy":"PWEST","dateCreated":"2003-05-09","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"4","valueDescription":"IV","ValueMeaning":{"publicId":"2559008","version":"1","preferredName":"IV","longName":"2559008","preferredDefinition":"Stage IV","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B38D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CURTIST","dateModified":"2009-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD415FAB-583B-0AA0-E034-0003BA12F5E7","beginDate":"2003-05-09","endDate":null,"createdBy":"PWEST","dateCreated":"2003-05-09","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"5","valueDescription":"V","ValueMeaning":{"publicId":"2565933","version":"1","preferredName":"V","longName":"2565933","preferredDefinition":"Stage V","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CE9A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-09","endDate":null,"createdBy":"PWEST","dateCreated":"2003-05-09","modifiedBy":"PWEST","dateModified":"2003-05-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD415FAB-583E-0AA0-E034-0003BA12F5E7","beginDate":"2003-05-09","endDate":null,"createdBy":"PWEST","dateCreated":"2003-05-09","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Unknown/NA","valueDescription":"UNKNOWN/NOT APPLICABLE","ValueMeaning":{"publicId":"2560404","version":"1","preferredName":"UNKNOWN/NOT APPLICABLE","longName":"2560404","preferredDefinition":"UNKNOWN/NOT APPLICABLE","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B901-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD415FAB-5841-0AA0-E034-0003BA12F5E7","beginDate":"2003-05-09","endDate":null,"createdBy":"PWEST","dateCreated":"2003-05-09","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"III, IV, or bulky stage II","valueDescription":"III, IV, or bulky stage II","ValueMeaning":{"publicId":"3235947","version":"1","preferredName":"III, IV, or bulky stage II","longName":"3235947","preferredDefinition":"III, IV, or bulky stage II","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3A502D9-7839-4FE2-E040-BB89AD4302A8","latestVersionIndicator":"Yes","beginDate":"2011-05-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-05-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A3A502D9-7852-4FE2-E040-BB89AD4302A8","beginDate":"2011-05-19","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-05-19","modifiedBy":"ONEDATA","dateModified":"2011-05-19","deletedIndicator":"No"},{"value":"Ballantyne Stage II/recurrent","valueDescription":"Stage II Recurrent","ValueMeaning":{"publicId":"5978072","version":"1","preferredName":"Stage II Recurrent","longName":"5978072","preferredDefinition":"Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites.: occurring again.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II","conceptCode":"C28054","definition":"Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Recurrent","conceptCode":"C14173","definition":"Occurring again.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"59102CA9-9C49-6158-E053-F662850A811C","latestVersionIndicator":"Yes","beginDate":"2017-09-13","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-09-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"59102CA9-9C62-6158-E053-F662850A811C","beginDate":"2017-09-13","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-09-13","modifiedBy":"ONEDATA","dateModified":"2017-09-13","deletedIndicator":"No"},{"value":"Ballantyne stage I","valueDescription":"Stage I","ValueMeaning":{"publicId":"3179338","version":"1","preferredName":"Stage I","longName":"3179338","preferredDefinition":"Invasive cancer confined to the original anatomic site of growth without lymph node involvement.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I","conceptCode":"C27966","definition":"Invasive cancer confined to the original anatomic site of growth without lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98906CB0-F8FD-EAA3-E040-BB89AD433105","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"59102CA9-9C76-6158-E053-F662850A811C","beginDate":"2017-09-13","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-09-13","modifiedBy":"ONEDATA","dateModified":"2017-09-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184339","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"Stage","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-20A0-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD40DA4C-D93A-0A9E-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-05-09","endDate":null,"createdBy":"PWEST","dateCreated":"2003-05-09","modifiedBy":"MORENOC","dateModified":"2017-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"COG Staging:","type":"Preferred Question Text","description":"COG Staging:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB70FDB0-7ACD-4C62-E053-4EBD850AA0EB","latestVersionIndicator":"Yes","beginDate":"2015-08-20","endDate":null,"createdBy":"MENARDP","dateCreated":"2021-09-07","modifiedBy":"MENARDP","dateModified":"2021-09-10","changeDescription":"Workflow and Registration Status changes per Brenda Duggan; 05.16.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}